Status:
COMPLETED
C-Reactive Protein (CRP) in Obese Diabetic Women
Lead Sponsor:
AstraZeneca
Collaborating Sponsors:
Mexican National Institute of Public Health
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
FEMALE
45+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether treatment with rosuvastatin for 6 months in obese type 2 diabetic women will improve their lipid profiles and thus prevent the progression to cardiova...
Eligibility Criteria
Inclusion
- Menopausal
- Diagnosed diabetes mellitus type 2
- Obese (body mass index \[BMI\] \> 25 ≤ 30)
Exclusion
- Fasting blood glucose ≥ 200 mg/dl
- CRP \< 2 mg/L and \> 10 mg/L
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00262548
Start Date
October 1 2005
Last Update
August 28 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research site
Cuernavaca, Morelos, Mexico